Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical, Pathological, and Genetic Characteristics of Patients with Digenic Alport Syndrome. | Kidney360 | 2024 | 39137047 | PubTator, text mining | PubMed |
| Case report: A novel compound heterozygous variant in the COL4A3 gene was identified in a patient with autosomal recessive Alport syndrome. | Front Genet | 2024 | 39071776 | PubTator, text mining | PubMed |
| Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome. | BMC Med Genomics | 2024 | 38978054 | PubTator, text mining | PubMed |
| Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study. | Am J Kidney Dis | 2024 | 38972501 | PubTator, text mining | PubMed |
| Monogenic Kidney Diseases in Adults With Chronic Kidney Disease (CKD). | Dtsch Arztebl Int | 2024 | 38958599 | PubTator, text mining | PubMed |
| Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy. | bioRxiv | 2024 | 38948788 | PubTator, text mining | PubMed |
| Investigation of missense mutation-related type 1 diabetes mellitus through integrating genomic databases and bioinformatic approach. | Genomics Inform | 2024 | 38926794 | PubTator, text mining | PubMed |
| Integrated Analysis Reveals COL4A3 as a Novel Diagnostic and Therapeutic Target in UV-Related Skin Cutaneous Melanoma. | Clin Cosmet Investig Dermatol | 2024 | 38911338 | PubTator, text mining | PubMed |
| Unraveling the Genetic Basis of Combined Deafness and Male Infertility Phenotypes through High-Throughput Sequencing in a Unique Cohort from South India. | Adv Genet (Hoboken) | 2024 | 38884051 | PubTator, text mining | PubMed |
| Liposome-lentivirus for miRNA therapy with molecular mechanism study. | J Nanobiotechnology | 2024 | 38858736 | PubTator, text mining | PubMed |
| Glomerular Endothelial Cell Receptor Adhesion G-Protein-Coupled Receptor F5 (ADGRF5) and the Integrity of the Glomerular Filtration Barrier. | J Am Soc Nephrol | 2024 | 38844335 | PubTator, text mining | PubMed |
| A targeted gene panel illuminates pathogenesis in young people with unexplained kidney failure. | J Nephrol | 2024 | 38837003 | PubTator, text mining | PubMed |
| A Novel COL4A5 Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease. | Genes (Basel) | 2024 | 38790225 | PubTator, text mining | PubMed |
| Genotype-Phenotype Correlations in Alport Syndrome-A Single-Center Experience. | Genes (Basel) | 2024 | 38790222 | PubTator, text mining | PubMed |
| Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases. | Orphanet J Rare Dis | 2024 | 38790019 | PubTator, text mining | PubMed |
| Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology. | Kidney Int Rep | 2024 | 38765603 | PubTator, text mining | PubMed |
| Coexisting presentation of two rare genetic variants of autosomal dominant polycystic kidney disease and Alport syndrome. | BMJ Case Rep | 2024 | 38740443 | PubTator, text mining | PubMed |
| Kidney Cysts in Children With Alport Syndrome: A Report of 3 Cases. | Kidney Med | 2024 | 38680391 | PubTator, text mining | PubMed |
| X-linked Alport syndrome presenting in mother and son with the same unique histopathological features. | J Nephrol | 2024 | 38668984 | PubTator, text mining | PubMed |
| Reclassification of Genetic Testing Results: A Case Report Demonstrating the Need for Structured Re-Evaluation of Genetic Findings. | Can J Kidney Health Dis | 2024 | 38623282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=9